Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Proyectos

Therapeutic impact of ApoJ/Clusterin-coupled liposomes on Alzheimer's disease experimental models

IP: Maria Mar Hernandez Guillamon
Colaboradores: Elena Antima Martinez Saez
Entidad financiadora: Fundació La Marató de TV3
Financiación: 200000
Referencia: 20141910
Duración: 17/02/2015 - 31/01/2019

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Colaboradores: Ignacio Ferreira González, José Antonio Barrabés Riu, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Rafael Simó Canonge, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 825000
Referencia: PIE13/00027
Duración: 01/01/2014 - 30/06/2018

INVICTUS

IP: Joan Montaner Villalonga
Colaboradores: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 247695.66
Referencia: RD12/0014/0005
Duración: 01/01/2013 - 31/03/2017

Role of Apolipoproteins (ApoE, ApoJ and ApoA-1) in Cerebral Amyloid Angiopathy: study of â-amyloid traffic across the blood brain barrier

IP: Joan Montaner Villalonga
Colaboradores: Maria Mar Hernandez Guillamon, Laia Perez Lasarte
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 202500
Referencia: MS12/03259
Duración: 01/01/2013 - 31/12/2017